Pacific Biosciences GenomeWeb Index Takes 7 Percent Tumble in September The GenomeWeb Index underperformed the Dow Jones, the Nasdaq, and the Nasdaq Biotechnology Index last month. Canaccord Genuity Initiates Coverage of Pacific Biosciences With Buy Rating PacBio's recent acquisition of Omniome, a short-read sequencing technology firm, is "a true game changer," Canaccord Genuity analyst Kyle Mikson said. Speedy Long-Read Genome Assembly Enabled by Minimizer-Space Analysis The minimizer-space de Bruijn graph approach could assemble a human genome in less than 10 minutes using eight cores and 10 gigabytes of random access memory. ABRF Study Benchmarks NGS Platforms on Human, Microbial Samples, Provides Peek at Genapsys Data Premium Illumina's NovaSeq, Oxford Nanopore's Flongle, and Genapsys were among the winners based on the results of the multiyear, multi-center NGS study. Pacific Biosciences Scores Victory in China in Patent Dispute With Taiwanese Firm PacBio said it has successfully petitioned for the invalidation of a Chinese patent held by Personal Genomics of Taiwan, which sued the firm for infringing its IP. Aug 4, 2021 Pacific Biosciences Hopes Circulomics Tech Will Help Standardize HiFi Sequencing Yield Premium Aug 3, 2021 Pacific Biosciences Q2 Revenues Grow 79 Percent Aug 3, 2021 Pacific Biosciences Acquires Sample Preparation Firm Circulomics Jul 20, 2021 PacBio's Omniome Acquisition Aims to Shorten Path to Clinical Testing Market Premium Jul 20, 2021 Pacific Biosciences to Acquire Omniome for up to $800M, Expand Invitae Collaboration Jul 1, 2021 GenomeWeb Index Up in June as Pacific Biosciences Shares Jump 29 Percent Jun 23, 2021 Pacific Biosciences, Rady Children's Collaborate on Study of WGS-Based Rare Disease Dx Jun 3, 2021 Telomere-To-Telomere Team Assembles Complete Human Genome En Route to Reference Pangenome Premium May 21, 2021 People in the News: New Appointments at Illumina, Pacific Biosciences, Qiagen, Quanterix, More Apr 30, 2021 New Products Posted to GenomeWeb: Pacific Biosciences, Paragon Genomics, Bio-Techne, More Apr 30, 2021 Pacific Biosciences Sees Opportunity in Kits for COVID-19, Pathogen Surveillance Premium Apr 29, 2021 Pacific Biosciences Q1 Revenues Soar 86 Percent Apr 1, 2021 GenomeWeb Index Falls Again in March, Led by 29 Percent Decline in Adaptive Biotech Stock Mar 23, 2021 Long-Read Sequencing Emerges as Useful Tool to Study RNA Isoforms Premium Mar 3, 2021 Human Pangenome Reference Consortium Releases Data From 30 Genomes Feb 10, 2021 Pacific Biosciences Reports 3 Percent Decrease in Q4 Revenues Feb 10, 2021 Pacific Biosciences to Obtain $900M Investment From SoftBank Subsidiary Jan 26, 2021 Hong Kong Team Develops Method to Improve PacBio Direct Cytosine Methylation Detection Premium Jan 14, 2021 Pacific Biosciences CEO Discusses Q4 Results, New Sequencing Platforms at JP Morgan Jan 13, 2021 Pacific Biosciences, Invitae to Develop Clinical Whole-Genome Sequencing Platform Load More Breaking News Delic Partners With GT Research for Genetic Analysis of Cannabis, Psychedelic Mushrooms Indivumed, Biognosys Expand Partnership to Offer Immunopeptidomics Insights Multiomic Study Identifies Drivers of Severe COVID-19 in Patients Under 50 Without Comorbidities Yourgene H1 2022 Revenues More Than Double Gencove Raises $10M in Series A Financing Blueprint Genetics, BioMarin to Offer Genetic Testing for Skeletal Dysplasia in Europe, Middle East The Scan Should've Been Spotted Sooner Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier. For Martian Fuel Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo. To Boost Rapid Testing The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests. PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.